Cargando…
Incidence of penile cancer worldwide: systematic review and meta-analysis
OBJECTIVE. To determine the global incidence of penile cancer. METHODS. A systematic review and meta-analysis of observational studies was performed, with no limits on their language of publication. Analyses were performed using Stata 13 statistical software. A random-effects model was used, accordi...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Organización Panamericana de la Salud
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6645409/ https://www.ncbi.nlm.nih.gov/pubmed/31384255 http://dx.doi.org/10.26633/RPSP.2017.117 |
_version_ | 1783437455086583808 |
---|---|
author | Montes Cardona, Carlos Eduardo García-Perdomo, Herney Andrés |
author_facet | Montes Cardona, Carlos Eduardo García-Perdomo, Herney Andrés |
author_sort | Montes Cardona, Carlos Eduardo |
collection | PubMed |
description | OBJECTIVE. To determine the global incidence of penile cancer. METHODS. A systematic review and meta-analysis of observational studies was performed, with no limits on their language of publication. Analyses were performed using Stata 13 statistical software. A random-effects model was used, according to the heterogeneity found in the studies. The main outcome was expressed in terms of age-standardized incidence. RESULTS. A total of 23 studies were eligible, with 71 156 penile cancer patients in 86 countries. According to the review conducted, the estimated age-standardized incidence of penile cancer worldwide is 0.84 cases per 100 000 person-years (95% confidence interval: 0.79–0.89). Romania reported the highest incidence, 7.26 per 100 000 person-years, between 1983 and 1987; however, some countries in Latin America and Africa reported an incidence of between 2.0 and 5.7 per 100 000. CONCLUSIONS. Penile cancer is considered a rare malignancy due to its already-known, particularly low incidence rate. The estimated age-standardized incidence rate by the world standard population today is 0.84 cases per 100 000 person-years. There were no significant differences in the incidence rate of penile cancer with respect to the distribution by continent or the trend over time. |
format | Online Article Text |
id | pubmed-6645409 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Organización Panamericana de la Salud |
record_format | MEDLINE/PubMed |
spelling | pubmed-66454092019-08-05 Incidence of penile cancer worldwide: systematic review and meta-analysis Montes Cardona, Carlos Eduardo García-Perdomo, Herney Andrés Rev Panam Salud Publica Review OBJECTIVE. To determine the global incidence of penile cancer. METHODS. A systematic review and meta-analysis of observational studies was performed, with no limits on their language of publication. Analyses were performed using Stata 13 statistical software. A random-effects model was used, according to the heterogeneity found in the studies. The main outcome was expressed in terms of age-standardized incidence. RESULTS. A total of 23 studies were eligible, with 71 156 penile cancer patients in 86 countries. According to the review conducted, the estimated age-standardized incidence of penile cancer worldwide is 0.84 cases per 100 000 person-years (95% confidence interval: 0.79–0.89). Romania reported the highest incidence, 7.26 per 100 000 person-years, between 1983 and 1987; however, some countries in Latin America and Africa reported an incidence of between 2.0 and 5.7 per 100 000. CONCLUSIONS. Penile cancer is considered a rare malignancy due to its already-known, particularly low incidence rate. The estimated age-standardized incidence rate by the world standard population today is 0.84 cases per 100 000 person-years. There were no significant differences in the incidence rate of penile cancer with respect to the distribution by continent or the trend over time. Organización Panamericana de la Salud 2017-11-30 /pmc/articles/PMC6645409/ /pubmed/31384255 http://dx.doi.org/10.26633/RPSP.2017.117 Text en https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 IGO License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited. No modifications or commercial use of this article are permitted. In any reproduction of this article there should not be any suggestion that PAHO or this article endorse any specific organization or products. The use of the PAHO logo is not permitted. This notice should be preserved along with the article’s original URL. |
spellingShingle | Review Montes Cardona, Carlos Eduardo García-Perdomo, Herney Andrés Incidence of penile cancer worldwide: systematic review and meta-analysis |
title | Incidence of penile cancer worldwide: systematic review and meta-analysis |
title_full | Incidence of penile cancer worldwide: systematic review and meta-analysis |
title_fullStr | Incidence of penile cancer worldwide: systematic review and meta-analysis |
title_full_unstemmed | Incidence of penile cancer worldwide: systematic review and meta-analysis |
title_short | Incidence of penile cancer worldwide: systematic review and meta-analysis |
title_sort | incidence of penile cancer worldwide: systematic review and meta-analysis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6645409/ https://www.ncbi.nlm.nih.gov/pubmed/31384255 http://dx.doi.org/10.26633/RPSP.2017.117 |
work_keys_str_mv | AT montescardonacarloseduardo incidenceofpenilecancerworldwidesystematicreviewandmetaanalysis AT garciaperdomoherneyandres incidenceofpenilecancerworldwidesystematicreviewandmetaanalysis |